Skip to content Home / Companies / VCYT VCY
VERACYTE, INC. (VCYT) XNAS SERVICES-MEDICAL LABORATORIES Net insider selling (90d) Watch VCYT
Latest VCYT Insider Trades
About VERACYTE, INC. (VCYT) Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Headquarters SOUTH SAN FRANCISCO, CA
Employees 755
Listed 2013
Exchange XNAS https://www.veracyte.com SEC filings for VCYT on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 8 162,492 $8.15M Grant or award 8 42,176 Option exercise 2 276,102
VCYT Insider Transactions (Form 4) 49 82 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 1 of 3.
Date Insider Transaction Security Shares Price Value Jun 18, 2026 KE Karin Eastham - Director Open-market sale Common Stock 3,200
Recent VCYT Form 8-K Filings 5
Recent VCYT Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jun 18, 2026 - - - - View on EDGAR Jun 4, 2026 - - -
VCYT Insider Trading - FAQ
What is the latest insider trade for VCYT? VERACYTE, INC. (VCYT) had 15 insider filings in the last 90 days, with the most recent on 2026-06-22. The full record for VCYT runs to 82 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying VCYT stock? No insider purchases of VCYT were filed in the last 90 days.
How many insiders are selling VCYT stock? 8 insider sales of VCYT were filed in the last 90 days, totaling $8.15M.
Where can I see VCYT SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks VCYT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow VCYT insider buys? Create a free InsiderAlpha account and press Watch on this page to add VCYT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track VCYT insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free JL John Leite - Officer Open-market sale $700K
Jun 4, 2026
Market cap $3.48B
P/E ratio 31.10
Dividend yield -
Average volume 1.36M
52 week high $60.91
52 week low $28.55
Today's high -
Today's low -
Open -
Volume -
Previous close $43.34
Shares outstanding 80.39M Market cap
$3.48B
755 employees
VCYT Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 8 sales totaling $8.15M.
Most-Active VCYT Insiders - Last 90 Days 10 Tax withholding / forfeiture 6 25,147
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 18, 2026 KE Karin Eastham - Director Open-market sale Common Stock 529 $53.55 $28K
Jun 11, 2026 KE Karin Eastham - Director Grant or award Common Stock 5,272 $0.00 -
Jun 11, 2026 EJ Evan/ Fa Jones - Director Grant or award Common Stock 5,272 $0.00 -
Jun 11, 2026 EB Eliav Barr - Director Grant or award Common Stock 5,272 $0.00 -
Jun 11, 2026 JH Jens Holstein - Director Grant or award Common Stock 5,272 $0.00 -
Jun 11, 2026 MB Muna Bhanji - Director Grant or award Common Stock 5,272 $0.00 -
Jun 2, 2026 AM Annie McGuire - Officer Tax withholding / forfeiture Common Stock 3,292 $47.80 $157K
Jun 4, 2026 AM Annie McGuire - Officer Open-market sale Common Stock 1,400 $49.31 $69K
Jun 4, 2026 AM Annie McGuire - Officer Open-market sale Common Stock 1,776 $50.12 $89K
Jun 2, 2026 JW Jonathan Wygant - Officer Tax withholding / forfeiture Common Stock 1,361 $47.80 $65K
Jun 2, 2026 RC Rebecca Chambers - Officer Tax withholding / forfeiture Common Stock 3,693 $47.80 $177K
Jun 4, 2026 RC Rebecca Chambers - Officer Open-market sale Common Stock 1,600 $49.28 $79K
Jun 4, 2026 RC Rebecca Chambers - Officer Open-market sale Common Stock 1,961 $50.09 $98K
Jun 2, 2026 PF Phillip G. Febbo - Officer Tax withholding / forfeiture Common Stock 3,730 $47.80 $178K
Jun 2, 2026 MS Marc Stapley - Officer Tax withholding / forfeiture Common Stock 9,012 $47.80 $431K
Jun 4, 2026 MS Marc Stapley - Officer Option exercise Common Stock 138,051 $36.60 $5.05M
Jun 4, 2026 MS Marc Stapley - Officer Open-market sale Common Stock 138,051 $50.12 $6.92M
Jun 4, 2026 MS Marc Stapley - Officer Option exercise Stock Option (right to buy) 138,051 $0.00 -
Jun 2, 2026 JL John Leite - Officer Tax withholding / forfeiture Common Stock 4,059 $47.80 $194K
Jun 4, 2026 JL John Leite - Officer Open-market sale Common Stock 13,975 $50.07 $700K
May 22, 2026 JW Jonathan Wygant - Officer Option exercise Common Stock 24,000 $24.80 $595K
May 22, 2026 JW Jonathan Wygant - Officer Open-market sale Common Stock 24,000 $45.40 $1.09M
May 22, 2026 JW Jonathan Wygant - Officer Option exercise Stock Option (right to buy) 24,000 $0.00 -
May 20, 2026 RE Robert S. Epstein - Director Open-market sale Common Stock 10,000 $44.01 $440K
May 6, 2026 AM Annie McGuire - Officer Open-market sale Common Stock 5,102 $38.05 $194K
May 6, 2026 AM Annie McGuire - Officer Open-market sale Common Stock 5,102 $40.00 $204K
Mar 6, 2026 JW Jonathan Wygant - Officer Grant or award Common Stock 10,525 $0.00 -
Mar 6, 2026 AM Annie McGuire - Officer Grant or award Common Stock 32,892 $0.00 -
Mar 6, 2026 AM Annie McGuire - Officer Grant or award Common Stock 26,314 $0.00 -
Mar 6, 2026 JL John Leite - Officer Grant or award Common Stock 36,181 $0.00 -
Mar 6, 2026 JL John Leite - Officer Grant or award Common Stock 6,578 $0.00 -
Mar 6, 2026 MS Marc Stapley - Officer Grant or award Common Stock 92,099 $0.00 -
Mar 4, 2026 RC Rebecca Chambers - Officer Open-market sale Common Stock 13,941 $36.33 $506K
Mar 4, 2026 RC Rebecca Chambers - Officer Open-market sale Common Stock 4,400 $35.55 $156K
Mar 4, 2026 MS Marc Stapley - Officer Open-market sale Common Stock 26,279 $36.28 $953K
Mar 4, 2026 MS Marc Stapley - Officer Open-market sale Common Stock 19,244 $35.56 $684K
Mar 4, 2026 JL John Leite - Officer Open-market sale Common Stock 5,260 $35.19 $185K
Mar 4, 2026 AM Annie McGuire - Officer Open-market sale Common Stock 4,994 $35.29 $176K
Mar 4, 2026 AM Annie McGuire - Officer Open-market sale Common Stock 1,664 $36.34 $60K
Mar 2, 2026 AM Annie McGuire - Officer Tax withholding / forfeiture Common Stock 6,902 $36.01 $249K
$ACON
Aclarion, Inc.
DS